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Abstract: Metal-mediated intracellular reactions are becoming 
invaluable tools in chemical and cell biology, and promise to strongly 
impact the field of biomedicine. Most of the reactions so far reported 
involve uncaging or redox processes. We now demonstrate for the 
first time the viability of performing multicomponent alkyne 
cycloaromatizations inside live mammalian cells, using ruthenium 
catalysts. Both, fully intramolecular and intermolecular cycloadditions 
of diynes with alkynes are feasible, the latter providing for the 
intracellular synthesis of appealing anthraquinones. The power of the 
approach is further demonstrated by generating anthraquinone 
AIEgens that otherwise do not go inside cells, and by modifying the 
intracellular distribution of the products by simply varying the type of 
ruthenium complex. 
Introduction 
Cells can be viewed as complex, tiny factories performing 
thousands of simultaneous chemicals reactions.1 As chemists, we 
are not bound to reproduce natural processes, and can therefore 
aspire at conducting non-coded catalytic reactions within living 
environments. While native enzymatic transformations are 
unbeatable with regard to rate and selectivity, abiotic catalytic 
processes might be advantageous in terms of versatility and 
substrate scope.2 Furthermore, introducing non-natural reactivity 
in cellular contexts can provide unprecedented opportunities for 
cellular and metabolic intervention.3 However, performing 
exogenous catalytic reactions within living cells is far from trivial, 
as it requires to maneuver among multitude of components and 
functional groups, and in an aqueous, crowded and 
compartmentalized environment.  
For many years, it was considered that organometallic catalysis 
was incompatible with aqueous and biological environments; 
however, the last decade has witnessed an increasing number of 
reports on bioorthogonal, and even intracellular transformations, 
mediated by transition metals.4 However, the repertoire of 
reactions is yet scarce, and mainly limited to uncaging 
processes;5 albeit other reactions, like reductions,6 
isomerizations7 and cyclizations,8 have also been recently 
introduced. Therefore, there is a great interest in increasing the 
repertoire of metal-mediated reactions that can be performed in 
live settings, as this will contribute to further establish this field, 
and expand its biotech and biomedical potential. A particularly 
attractive type of transformations are cycloaddition reactions, 
owing to their synthetic power, and the lack natural counterparts, 
albeit there have been claims on the existence of Diels-
Alderases.9  
Intracellular cycloadditions promoted by transition metals have 
been limited to sporadic applications of the renowned copper-
mediated alkyne-azide cycloaddition (CuAAC) (Figure 1, i),10 a 
key reaction for the establishment of the field of bioorthogonal 
chemistry.11 Unfortunately, its efficiency in intracellular settings is 
compromised by the toxicity and oxidation lability of copper. We 
recently developed a ruthenium-mediated alternative that 
involves thioalkynes as azide partners (Figure 1, ii). However, it 
couldn’t be implemented inside living cells.12 
At some point of our research we envisioned that moving from 
alkynes to appropriately tethered diynes, there might be better 
chances for bioorthogonal “fishing” of transition metal reagents 
owing to the bidentate η2 coordination ability of the substrate (A, 
Figure 1).13 An ensuing oxidative cyclometallation would give a 
metallacycle (B/C, Figure 1) that could be trapped by another 
alkyne to provide aromatic adducts formally resulting from a 
(2+2+2) cycloaddition (D, Figure 1, iii). This type of 
cyclotrimerization of alkynes is well-known in the realm of 
synthetic chemistry,14 and has also been even accomplished in 
aqueous media, using Co, Rh, or Ru catalysts;15,16 but never in a 
cellular context. 
In this manuscript we demonstrate the viability of this process, 
by reporting the first examples of a multicomponent cycloaddition 
carried out in the interior of live, unfixed mammalian cells. The 
reaction, which is mediated by non-toxic ruthenium complexes, 
allows to make three C-C bonds, and at least two new cycles, in 
a single step, therefore enabling a remarkable increase in 
structural complexity. 
We demonstrate that the cyclotrimerization is not only viable in 
fully intramolecular cases, but also when using isolated alkynes 
as external reaction partners (Figure 1, iv and v). Remarkably, this 
latter reaction allows to generate “in cellulae” anthraquinones, 
secondary metabolites which cannot be produced by mammalian 
cells. We also demonstrate that whereas anthraquinone 
derivatives with AIE (aggregation induced emission) 
characteristics do not internalize, they can be indirectly 
“introduced” inside cells using our reaction. We can even go one 
step further and promote the preferential generation of 
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Figure 1. Upper: i) CuAAC, feasible in living mammalian cells using specific 
formulations of Cu;10 ii) RutAAC, can be performed in cell lysates.12 Bottom: 
Left: mechanistic rational behind the orthogonality of the proposed 
cycloaddition; right: (2+2+2) cycloadditions. 
Results and Discussion 
Our initial experiments were planned considering previous work 
of Cadierno and coworkers,15b and of Teply,16 demonstrating the 
viability of achieving cyclotrimerizations of alkynes under different 
aqueous conditions, using [RuCp*Cl(COD)] (Ru1) as catalyst. 
However, these reactions were carried out using relatively high 
concentration of reactants, and required long reaction times, 
which raised doubts on their exportability to biological 
environments. We first tested the cyclotrimerization of triyne 1, 
because it is an intramolecular process, and the resulting 
pentacyclic product 2 is fluorescent (Figure 2a), thereby providing 
for tracking the reaction using microscopy. After some 
optimization, we managed to accomplish the reaction in complex 
biological media such as phosphate-buffered saline solution 
(PBS), cell culture media (DMEM) and HeLa cell lysates, even 
using micromolar concentrations of the precursor (Figure 2a). 
We then moved to a real biological scenario, a mammalian living 
cell. Therefore, HeLa cells were incubated with Ru1 and washed 
twice with DMEM to remove the excess of the complex. The 
presence of ruthenium inside cells was confirmed by ICP-MS 
analysis (Figure S17). Then, cells were mixed with substrate 1 for 
1 h. Panel A in figure 2b displays the cells after treatment only 
with substrate 1, which show no fluorescence. In contrast, we did 
observe some fluorescence in cells that had been pretreated with 
Ru1 (panel B), in agreement with the formation of the product 2. 
Remarkably, using the complex Ru2, which we knew from 
previous studies that presents a good cellular uptake and 
tolerance,5e we observed a more intense intracellular emission 
(Figure 2b, panel C), consisting with the generation of a larger 
amount of product. Indeed, we calculated a three-fold higher 
fluorescence intensity when compared with that resulting from the 
use of Ru1 (Figure 2c). The ruthenium (IV) complex Ru2 is likely 
reduced in situ to an active Ru(II) species;5d and its better 
performance in cells seems in part associated to an improved 
uptake with respect to Ru1 (Section S12). The processes didn’t 
produce observable changes in the morphology of the cells or 
affect the survival at the operating times (Figure S8). 
 
 
Figure 2. (a) Ruthenium-mediated annulation of triyne 1 in aqueous buffers. (b) 
Fluorescence micrographies of Hela cells (brightfield) after incubation with: (A) 
1; (B) Ru1, washed, and treated with 1; (C) Ru2, washed, and treated with 1; 
conditions: cells were incubated with [Ru] (50 μM) for 30 min, followed by two 
washings with DMEM, and treatment with substrate 1 (100 μM) for 1 h. Blue 
channel: λexc = 385 nm, λem = 410-480 nm. (c) CTCF measurements (corrected 
total cell fluorescence). Error bars from three independent experiments. Scale 
bar: 12.5 μm. a Performed using substrate 1 (5 mmol), milieu (5.0 mL), Ru1 (25 
mol%), 25 °C, 24 h; Yields determined by NMR using an internal standard. b 
Cell lysates 6 mg/mL. Note: counterions in Ru2 should be Br- and PF6-. 
The above results are consistent with the generation of product 2 
inside cells, through a formal (2+2+2) multicomponent annulation. 
Albeit the intramolecularity of the process might favor the 
annulation, we envisioned that once ruthenacycle intermediates 
like B (Figure 1b) are formed, they could be trapped with external 
alkynes (Figure 1, v). Gratifyingly, treatment of diyne 3 with 
terminal alkyne 4a (4 equiv), in water, gave the expected 
phthalan-like product in 60% yield, after only 2 h, using 25% of 
Ru1 (Figure 3a). The yield increases up to 94% when the reaction 
is carried out in a phosphate-buffered saline solution (PBS). The 
reaction also takes place in DMEM and in presence of HeLa cell 
lysates (95% and 89% yields, respectively, Figure 3a), and can 
be promoted with other complexes like [CpRu(CH3CN)3]PF6 or 
Ru2, which gave the product in modest yields of 38 and 14% 
(respectively) in PBS (Table S1).		
The success of the reaction with the model precursor 3, prompted 
us to investigate the generation of fluorescent and/or biologically 
relevant products. In particular, we were attracted by 
anthraquinone skeletons (AQ), as they form the core of many 
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a) Intramolecular (2+2+2) Ru-mediated cycloadditiona
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Figure 3. (a) Formal (2+2+2) cycloadditions in complex aqueous media. (b) 
Plausible biological pathway for the synthesis of anthraquinones. a Performed 
using substrate 3 or 6 (5 μmol), milieu (5.0 mL), 25 °C, 2 h; b Cell lysates 2 
mg/mL; Yields determined by NMR using an internal standard. Number of 
replicates: between 2 and 4, and errors in yields range between 3-6%.  
The AQ skeleton could be assembled in a single step by means 
of a Ru-promoted annulation between bispropargylic ketones of 
type 6 and terminal alkynes (Figure 3a, bottom).18 In nature, the 
main polycyclic core of AQs is biosynthesized from acetylCoA and 
MalonylCoA, in a multistep process governed by the multi-domain 
enzyme polyketide synthase (PKs) present in some plants, fungi, 
insects and bacteria (Figure 3b). However, mammalian cells do 
not code for the biosynthesis of AQs, which added further interest 
to explore the possibility of building these products inside these 
cells. 
Gratifyingly, the bispropargylic ketone 6a reacted with 
commercially available alkyne 4a (4 equiv) in presence of Ru1 
(50%) to give the expected tricycle 7a in 79% yield after 2 h at rt, 
in water (Figure 3a, bottom). The catalyst loading can be reduced 
to 25%, albeit there is a decrease in the yield (59%). Importantly, 
the concentration of 6a could be decreased to 500 μM (53% yield). 
The reaction can be also accomplished in phosphate-buffered 
saline (PBS) even at 25% of Ru1 (65% yield). In cell culture media, 
such as DMEM, or in HeLa cell lysates the reaction presents 
almost no turnover (37 and 28% respectively, using 25% of Ru1). 
The cycloaddition is also feasible using an internal 1,6-diyne such 
as 6b, albeit it was somewhat slower (45% yield, using 50% of 
Ru1 in water). In this case, we found that the use of an organic 
co-solvent (H2O/MeCN 8:2), allowed a slightly better yield (59%). 
Other terminal alkynes 4 also participate in the cycloaddition 
(Table S3). 
Substrates 6a and 4a are not fluorescent, however the 
anthraquinone product 7a presents bright green and blue 
fluorescence emission, which facilitates monitorization in cellular 
settings. For cellular experiments we preferred to use Ru2, owing 
to its better uptake5e (although catalyst Ru1 was also able to elicit 
the reaction in HeLa cells, Figure S10). These experiments were 
carried out by incubating the cells with Ru2, followed by treatment 
with alkyne 4a and diyne 6a (Figure 4a and S9). After 4 h, we 
were glad to observe an intense fluorescence build-up inside the 
cells, consistent with the formation of anthraquinone product 7a 
(Figure 4a, panels A, B).  
 
Figure 4. Intermolecular cycloadditions in live cells. (a) Fluorescence 
micrographies of HeLa cells (brightfield) after incubation with: (A) Ru2, washed, 
and treated with 6a and 4a; (B) similar, but observation under the green channel; 
(C) 6a and 4a; (D) product 7a. (b) Products with the triphenylphosphonium tails. 
Extracted ion chromatogram of the product 5P generated intracellularly 
(methanolic extract) and also that detected in the DMEM washings, before the 
extraction; (inset) mass spectrum of 5P. Conditions: HeLa cells pretreated with 
50 μM of Ru2 for 50 min were washed twice and incubated with 50 μM of 
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channel: λexc = 385 nm, λem = 410-480 nm; green channel: λexc = 470 nm, λem = 
490-580 nm. Scale bar: 12.5 μm.  
 
Control experiments confirmed that addition of anthraquinone 
product 7a to HeLa cells elicits a clear intracellular fluorescence 
(panel D, Figure 4a). In contrast, cells co-incubated with 
substrates 6a and 4a were nearly non-fluorescent (Figure 4a, 
panel C). As expected, addition of each component alone, either 
6a or 4a, to cells that had been previously treated with the 
ruthenium reagent, led only to residual intracellular fluorescence 
(arising from the substrates, Figure S10). 
The intracellular formation of AQ products was further 
confirmed by carrying out the reaction with the alkyne derivative 
4P, which features a phosphonium tail (Figure 4b). This group 
facilitates the identification of the product owing to its good 
performance in ESI-MS spectrometry. Therefore, MS analysis 
(extracted ion chromatogram) of methanolic extracts of cells 
treated with 4P, and either 3 or 6a, under the standard reaction 
conditions, revealed the presence of the expected cycloadducts 
(Figure 4b, Section S14). These results suggest that this type of 
molecular labels (phosphonium cations or similar), could allow to 
overcome the current limitation of detection tactics to fluorescent 
products. 
To further expand the scope and potential of the technology, we 
envisioned the synthesis of products with tetraphenylethylene 
skeletons like 9a, using alkyne 8a as reaction partner (Figure 5a). 
This type of structures, known to present aggregation-induced 
emission properties (AIE),19 are very attractive from a 
photophysical perspective.20 Unfortunately, while the alkyne 8a 
displays an excellent emission, the corresponding cycloadduct 9a 
presents a strong decrease in its AIEgen properties, perhaps 
because of an increased molecular rotation (Figure S11). 
However, AQ 9b, obtained from alkyne 8b, behaves as an 
excellent AIEgen (Figure 5a, Figure S12). 
Importantly, the product (9b) can be generated inside live 
mammalian cells using the cyclotrimerization reaction. Therefore, 
the addition of substrates 6a and 8b to HeLa cells previously 
treated with the ruthenium complex Ru2, leads to an intense 
intracellular red staining (Figure 5b, panel D, enlarged images in 
E, F). This result is especially significant because the 
anthraquinone 9b is unable to travel inside cells. Indeed, 
incubation of cells with the anthraquinone 9b leads to the 
formation of aggregates in the extracellular media (Figure 5b, 
panel G, and enlarged images in H, I). This product can be 
internalized only after permeabilization of the membrane with 
digitonin (Figure S16). Therefore, our approach allows to 
indirectly introduce in cells a product (anthraquinone 9b) that 
otherwise aggregates in the extracellular space. Importantly, 
these results further corroborate the intracellular character of the 
reaction. 
An additional asset of the strategy stems from the possibility of 
controlling the intracellular distribution of the AQ product 9b 
depending on the ruthenium reagent. Therefore, by using 
complex Ru1, the cellular fluorescence shows a cytosolic profile 
(slightly less intense than with Ru2, Figure 6, panels A-C). 
However, using complex Ru3, which is known to preferentially 
accumulate in mitochondria owing to its lipophilic cationic 
character,5e the fluorescence is mainly located in these organelles 
(Figure 6, panels D-F, Figure S13).  
Finally, it is important to note that in all the above experiments 
neither substrates nor products compromised the cell viability at 
the observation times, inducing only a slight decrease after 12 h 
of incubation at high concentrations (Figure S8).5e 
	
Figure 5. Intracellular generation of AIEgens. (a) Structures of the precursors, 
and cycloaddition products. (b) Fluorescence micrographies of HeLa cells 
(brightfield) after incubation with: (A) Ru2, washed, and treated with 6a; (B) Ru2, 
washed, and treated with 8b; (C) precursors 6a and 8b; (D) Ru2, washed, and 
treated with 6a and 8b; (E,F) Zoom in of panel D; (G) anthraquinone 9b; (H,I) 
Zoom in of panel G. Conditions: HeLa cells were incubated with Ru2 (50 μM) 
for 1 h, followed by two washings with DMEM, and treatment with substrates 6a 
and 8 (50 and 150 μM, respectively) for 3 h. Red channel: λexc = 550 nm, λem = 
570-690 nm. Scale bar: 12.5 μm. 
Conclusion 
In conclusion, our results demonstrate that transition metals can 
promote challenging (2+2+2) multicomponent cycloadditions in 
live mammalian cells. The use of abiotic reactants with bidentate 
metal coordination abilities (diyne) seems instrumental for the 
success of the process. In addition to provide a cutting-edge 
addition to the palette of cell-compatible metal-mediated 
transformations, our work demonstrates the viability of 
synthesizing complex, biorelevant polycycles inside cells from 
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simple precursors, and therefore goes beyond the more common 
uncaging or ligation reactions. Our intracellular synthetic strategy 
allows to generate products that otherwise cannot be delivered to 
the cell, as well as controlling their spatial distribution by using 
suitable ruthenium reagents. Indeed, the possibility of generating 
the desired products in specific subcellular locations, just by 
changing the targeting characteristics of the reagents, is exciting. 
While further work to increase the efficiency of the reactions is 
needed, our discoveries should further foster this young field of 
intracellular metal catalysis, and trigger important applications in 
chemical and synthetic biology, and in biomedicine.  
	
Figure 6. Reagent-dependent spatial distribution of the product of the 
reaction between 6a and 8b. Fluorescence micrographies of HeLa cells 
incubated with: (A,D) Ru1 or Ru3, respectively, washed, and treated with 6a 
and 8b (red channel); (B,E) mitochondrial labelling with TMRE 
(tetramethylrhodamine ethyl ester, green channel); (C) overlay of A and B; (F) 
overlay of D and E. Same conditions as in Figure 5. Cells were finally incubated 
with mitochondrial marker (100 nM) for 10 min. Scale bar: 12.5 μm. Note: 
counterions in Ru3 are Br- and PF6-. 
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Ruthenium-mediated cycloaromatization reactions engaging three alkyne units can be performed in intracellular settings, in a 
biocompatible way. This synthetically powerful reaction allows to build a variety of relatively complex, functional cyclic products inside 
cells, therefore providing an “artificial” metabolic route to these interesting species.    
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